Literature DB >> 3792062

Lung and blood lymphocyte subsets in asbestosis and in mixed dust pneumoconiosis.

U Costabel, K J Bross, E Huck, J Guzman, H Matthys.   

Abstract

To study the local distribution of lymphocyte subsets in inorganic dust diseases, bronchoalveolar lavage (BAL) was performed in seven patients with asbestosis, and in 13 patients with mixed dust pneumoconiosis (anthracosidero-silicosis). Lymphocyte subsets in BAL and blood were determined by the monoclonal antibodies OKT3 (pan T), OKT4 (helper/inducer), OKT8 (suppressor/cytotoxic), B1 (B-cells), OKIa (HLA-DR antigens), and Leu-7 (natural killer). The BAL lymphocytes were moderately elevated to 15 +/- 8 percent (mean +/- SD) in mixed dust pneumoconiosis, and even more markedly increased to 28 +/- 21 percent in asbestosis. The OKT4/OKT8 ratio in BAL was significantly increased to 4.5 +/- 2.1 in asbestosis, and significantly reduced to 0.9 +/- 0.8 in mixed dust pneumoconiosis. In blood, the ratio of T-cell subsets remained unchanged, though total lymphocytes were decreased in asbestosis. These results suggest altered cellular immune processes in the lungs of patients with pneumoconiosis and may indicate different immunoregulatory changes depending on the nature of the inhaled dust.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3792062     DOI: 10.1378/chest.91.1.110

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  3 in total

1.  Role of lymphocytes in silicosis: regulation of secretion of macrophage-derived mitogenic activity for fibroblasts.

Authors:  W Li; R K Kumar; R O'Grady; G M Velan
Journal:  Int J Exp Pathol       Date:  1992-12       Impact factor: 1.925

2.  Lymphocyte B and T cell subsets in peripheral blood from patients with asbestosis.

Authors:  L Peng; X Wang
Journal:  Br J Ind Med       Date:  1993-02

3.  Domestic mixed-dust pneumoconiosis: A case report and literature review.

Authors:  Faisal Mubarak Al Badri; Shahieda Adams
Journal:  Respir Med Case Rep       Date:  2019-12-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.